Pune, India -- (SBWIRE) -- 01/09/2018 -- "Global Dysfunctional Uterine Bleeding Market by Manufacturers, Countries, Type and Application, Forecast to 2023 Report "Provides In-Depth Analysis of Parent Market Trends, Macro-Economic Indicators and Governing Factors Along With Market Attractiveness as Per Segments.The global dysfunctional uterine bleeding market is expected to grow at a CAGR of 8.2% during the forecast period.

GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/4685 .

MarketResearchFuture.com adds "Dysfunctional Uterine Bleeding Market -2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023" reports to its database.

Market Synopsis of the Global Dysfunctional Uterine Bleeding Market;
Dysfunctional uterine bleeding (DUB) is abnormal genital tract bleeding based in the uterus without the presence of any structural or organic disease. Although the exact reason is unknown, it is usually a menstrual disorder due to hormonal disturbances such as reduced progesterone levels, increased levels of tissue plasminogen activator and others. However there are cases of abnormal bleeding from the uterus outside menstruation. The global dysfunctional uterine bleeding market is expected to grow at a CAGR of 8.2% during the forecast period of 2016 to 2023.

DUB is classified as ovulatory or anovulatory, depending on whether ovulation is occurring or not. 10% of cases occur in women who are ovulating, called as ovulatory DUB. About 90% of DUB is anovulatory with events occur when ovulation is not occurring and is common at the extremes of reproductive age, such as early puberty and perimenopause. The risk factors are psychological stress, weight changes such as obesity, anorexia, heavy exercise, endocrinopathy, neoplasm, drugs, etc. increasing cases of fibroids in the uterus, infection of the cervix, cancer of the uterus, polycystic ovary syndrome, endometriosis, and uterine polyps are also firing the growth of the market. According to the World Cancer Research Fund International, endometrial cancer is the sixth most common cancer in women worldwide, in 2015, with 53% of endometrial cancer cases occurring in the developed countries.

Segments of the Global Dysfunctional Uterine Bleeding Market:
Dysfunctional uterine bleeding market is segmented into type, diagnosis, and treatment. On the basis of type the market is sub-segmented into ovulatory and anovulatory. On the basis of diagnosis, the market is sub-segmented into physical examination, hysteroscopy, ultrasonography, blood tests and others. On the basis of type the market is sub-segmented into pharmacologic treatment, hysterectomy, endometrial ablation and others.

Based on the types the anovulatory segment occupies a lion's share of 90 %. The diagnostics segment is dominated by blood tests with ultrasonography taking greater and greater share of the market. The development of highly sensitive and selective blood tests has resulted in development of the market. The treatment segment is dominated by the pharmacologic treatment. However the endometrial ablation treatment is growing at the fastest CAGR and is expected to be so in the future.

GET FULL REPORT @ https://www.marketresearchfuture.com/reports/dysfunctional-uterine-bleeding-market-4685 .

Key Players in the Global Dysfunctional Uterine Bleeding Market:
Some of the key players in this market are B. Braun Melsungen AG (Germany), Hologic Inc. (U.S.), Karl Storz Gmbh & Co. KG (Germany), Medgyn Products, Inc., Olympus (Japan), Richard Wolf GmbH (Germany), Stryker (U.S.), Xion Medical GmbH (Germany), Cadila Pharmaceuticals Ltd. (India), Torrent Phamraceuticals (India).

1. Braun Melsungen AG, Stryker and Karl Storz Gmbh & Co. KG hold a lion's share of the market for dysfunctional uterine bleeding. However the drug segment has been growing moderately which is a cause of concern. Endometrial Ablation devices are the next wave which needs to be tapped with technologically advanced companies being in advantageous position. The market is fragmented which has exerted pressure on the prices. Thus product development is a strong strategy which will result in higher margin. High tech devices segment is also a better use of the high quality of manpower present in the company. For the low tech segment market development strategy will result in greater return on investment. Thus taking advantage of the global supply chains will be a tactical move to dominate the market.

Regional outlook of the Dysfunctional Uterine Bleeding market:
America is the largest market for dysfunctional uterine bleeding market across the globe. The market is driven by the rising prevalence of uterine cancer and other uterine disorders among women. According to the American Cancer Institute, about 61,380 new cases of uterine cancer is estimated to be diagnosed in 2017. Europe is the second largest market owing to an increasing demand for diagnosis and treatment measures for uterine cancer, fibroids and other disorders, and increasing emphasis on women healthcare.

The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing prevalence of menstrual disorders, rising awareness about causes of such disorders and early diagnosis and treatment measures among women. The market is also driven by rising prevalence of sexually transmitted diseases among women in the developing nations. Rising awareness is the key to the market as a large unmet need is present in the developing regions which has not been tapped due to the stigma associated with women gynaecological disorders.

The Middle East & Africa also show a steady rise in the market owing to increasing focus on women and child health, and need of primary care services in developing regions. Cost will be a major issue in the Middle East and Africa market. A first comer in the African market will benefit as it is difficult for any other company to dislodge the established player due to the lower volume of treatment. It would also be difficult for any new player to develop cost and scale efficiencies in such a highly competitive market.

...CONTINUED

GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/4685 .

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com